212 related articles for article (PubMed ID: 18230179)
1. Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer.
Costa S; Pinto D; Pereira D; Rodrigues H; Cameselle-Teijeiro J; Medeiros R; Schmitt F
BMC Cancer; 2008 Jan; 8():32. PubMed ID: 18230179
[TBL] [Abstract][Full Text] [Related]
2. Association of TP53 intron 3, 16 bp duplication polymorphism with esophageal and gastric cancer susceptibility in Kashmir Valley.
Malik MA; Sharma K; Goel S; Zargar SA; Mittal B
Oncol Res; 2011; 19(3-4):165-9. PubMed ID: 21473292
[TBL] [Abstract][Full Text] [Related]
3. Lack of influence of TP53 Arg72Pro and 16bp duplication polymorphisms on risk of breast cancer in Iran.
Gohari-Lasaki S; Gharesouran J; Ghojazadeh M; Montazeri V; Mohaddes Ardebili SM
Asian Pac J Cancer Prev; 2015; 16(7):2971-4. PubMed ID: 25854391
[TBL] [Abstract][Full Text] [Related]
4. Association of TP53 PIN3 polymorphism with breast cancer in Moroccan population.
Marouf C; Tazzite A; Diakité B; Jouhadi H; Benider A; Nadifi S
Tumour Biol; 2014 Dec; 35(12):12403-8. PubMed ID: 25201062
[TBL] [Abstract][Full Text] [Related]
5. TP53 polymorphisms in sporadic North Indian breast cancer patients.
Sharma S; Sambyal V; Guleria K; Manjari M; Sudan M; Uppal MS; Singh NR; Bansal D; Gupta A
Asian Pac J Cancer Prev; 2014; 15(16):6871-9. PubMed ID: 25169539
[TBL] [Abstract][Full Text] [Related]
6. No association of TP53 codon 72 and intron 3 16-bp duplication polymorphisms with breast cancer risk in Chinese Han women: new evidence from a population-based case-control investigation.
Hao W; Xu X; Shi H; Zhang C; Chen X
Eur J Med Res; 2018 Oct; 23(1):47. PubMed ID: 30309383
[TBL] [Abstract][Full Text] [Related]
7. TP53 gene polymorphisms and breast cancer in Croatian women: a pilot study.
Bisof V; Salihović MP; Narancić NS; Skarić-Jurić T; Jakić-Razumović J; Janićijević B; Turek S; Rudan P
Eur J Gynaecol Oncol; 2010; 31(5):539-44. PubMed ID: 21061796
[TBL] [Abstract][Full Text] [Related]
8. Intronic polymorphisms in TP53 indicate lymph node metastasis in breast cancer.
Hrstka R; Beranek M; Klocova K; Nenutil R; Vojtesek B
Oncol Rep; 2009 Nov; 22(5):1205-11. PubMed ID: 19787241
[TBL] [Abstract][Full Text] [Related]
9. Haplotype analysis of p53 polymorphisms: Arg72Pro, Ins16bp and G13964C in Tunisian patients with familial or sporadic breast cancer.
Trifa F; Karray-Chouayekh S; Mabrouk I; Baccouche S; Khabir A; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
Cancer Epidemiol; 2010 Apr; 34(2):184-8. PubMed ID: 20233677
[TBL] [Abstract][Full Text] [Related]
10. Lack of association of intron 3 16 bp polymorphism of TP53 with breast cancer among Iranian-Azeri patients.
Pouladi N; Kouhsari SM; Feizi MH; Dehghan R; Azarfam P; Farajzadeh D
Asian Pac J Cancer Prev; 2014; 15(6):2631-4. PubMed ID: 24761875
[TBL] [Abstract][Full Text] [Related]
11. TP53 codon 72 and intron 3 polymorphisms and mutational status in gastric cancer: an association with tumor onset and prognosis.
Neves Filho EH; Cordeiro DE; Vieira AP; Rabenhorst SH
Pathobiology; 2012; 79(6):323-8. PubMed ID: 22688387
[TBL] [Abstract][Full Text] [Related]
12. Association of TP53 codon 72 and intron 3 16-bp Ins/Del polymorphisms with cervical cancer risk.
Laprano TD; Lemos EH; Cunha LM; Júnior JE; de SousaTeles RA; Rabenhorst SH
Tumour Biol; 2014 Aug; 35(8):7435-40. PubMed ID: 24782034
[TBL] [Abstract][Full Text] [Related]
13. Association of PIN3 16-bp duplication polymorphism of TP53 with breast cancer risk in Mali and a meta-analysis.
Diakite B; Kassogue Y; Dolo G; Kassogue O; Keita ML; Joyce B; Neuschler E; Wang J; Musa J; Traore CB; Kamate B; Dembele E; Nadifi S; Isichei M; Holl JL; Murphy R; Doumbia S; Hou L; Maiga M
BMC Med Genet; 2020 Jul; 21(1):142. PubMed ID: 32620097
[TBL] [Abstract][Full Text] [Related]
14. p.R72P, PIN3 Ins16bp polymorphisms of TP53 and CCR5?32 in north Indian breast cancer patients.
Guleria K; Sharma S; Manjari M; Uppal MS; Singh NR; Sambyal V
Asian Pac J Cancer Prev; 2012; 13(7):3305-11. PubMed ID: 22994752
[TBL] [Abstract][Full Text] [Related]
15. The p53 Arg72Pro and Ins16bp polymorphisms and their haplotypes are not associated with breast cancer risk in BRCA-mutation negative familial cases.
De Vecchi G; Verderio P; Pizzamiglio S; Manoukian S; Bernard L; Pensotti V; Volorio S; Ravagnani F; Radice P; Peterlongo P
Cancer Detect Prev; 2008; 32(2):140-3. PubMed ID: 18640791
[TBL] [Abstract][Full Text] [Related]
16. Analysis of TP53 polymorphisms in North Indian sporadic esophageal cancer patients.
Kaur S; Sambyal V; Guleria K; Manjari M; Sudan M; Uppal MS; Singh NR; Singh G; Singh H
Asian Pac J Cancer Prev; 2014; 15(19):8413-22. PubMed ID: 25339039
[TBL] [Abstract][Full Text] [Related]
17. TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population.
Hossain A; Murshid GMM; Zilani MNH; Islam F; Sultana R; Sultana T; Hossain MG; Rahman MM
Breast Cancer; 2017 Jul; 24(4):571-578. PubMed ID: 27837441
[TBL] [Abstract][Full Text] [Related]
18. Linkage disequilibrium and haplotypes of five
Sambyal V; Kaur S; Manjari M; Uppal MS; Singh NR; Sudan M; Guleria K
J Genet; 2020; 99():. PubMed ID: 33622989
[TBL] [Abstract][Full Text] [Related]
19. The TP53 gene polymorphisms and survival of sporadic breast cancer patients.
Bišof V; Salihović MP; Narančić NS; Skarić-Jurić T; Jakić-Razumović J; Janićijević B; Rudan P
Med Oncol; 2012 Jun; 29(2):472-8. PubMed ID: 21365326
[TBL] [Abstract][Full Text] [Related]
20. TP53 PIN3 polymorphism associated with breast cancer risk in Iranian women.
Faghani M; Ghasemi FM; Nikhbakht M; Salehi M
Indian J Cancer; 2011; 48(3):298-302. PubMed ID: 21921327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
